BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

2
Player Avatar TMFBiologyFool (96.44) Submitted: 3/9/2011 3:13:27 PM : Outperform Start Price: $4.16 BCRX Score: +175.97

Will rise during next pandemic flu. When will that happen? I have no idea, but at this cheap price, it's not that hard to wait.

Featured Broker Partners


Advertisement